Intellia Therapeutics Inc buy Truist Financial Co.
Start price
24.06.24
/
50%
€23.43
Target price
24.06.25
€111.85
Performance (%)
-64.98%
End price
25.06.25
€8.21
Summary
This prediction ended on 25.06.25 with a price of €8.21. Massive losses of -64.98% were the result for the BUY prediction by Truist_Financial_Co_. Truist_Financial_Co_ has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 8.566% | 8.566% | 19.934% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $120.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.43
04.03.25
04.03.25
€47.44
04.03.26
04.03.26
38.28%
27.02.26
27.02.26
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.65
10.11.25
10.11.25
€12.11
10.11.26
10.11.26
34.86%
27.02.26
27.02.26